Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04421820 |
Title | BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Bold Therapeutics, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of California, Los Angeles | Santa Monica | California | 90095 | United States | Details | |
Moffitt Cancer Center | Tampa | Florida | 33612 | United States | Details | |
Cross Cancer Institue | Edmonton | Alberta | Canada | Details | ||
Juravinski Cancer Centre | Hamilton | Ontario | Canada | Details | ||
The Ottawa Hospital Cancer Centre | Ottawa | Ontario | Canada | Details | ||
Princess Margaret Cancer Centre | Toronto | Ontario | Canada | Details | ||
Jewish General Hospital | Montreal | Quebec | Canada | Details | ||
McGill University Health Centre Glen Site | Montréal | Quebec | Canada | Details | ||
National Cancer Center | Goyang | Korea, Republic of | Details | |||
Kangbuk Samsung Hospital | Seoul | Korea, Republic of | Details | |||
Samsung Medical Center | Seoul | Korea, Republic of | Details | |||
Seoul National University Hospital | Seoul | Korea, Republic of | Details | |||
Severance Hospital - Yonsei University | Seoul | Korea, Republic of | Details |